STING1 and lymphopenia: Reconstructing these clinical manifestations in STING N153S and V154M knock-in mice reveals the importance of IFN-independent activities of STING activation in controlling lung inflammation, myeloid cell expansion, and lymphopenia (Warner et al., 2017; Motwani et al., 2019a).